O. Demaria

Discipline

Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (8) Recensions (1)

Co-auteur

Date

Source

Mot-clé

Mice (6) Human beings (6) spectacle (5) Cells (5) Animals (5) peau (4) Skin (4) ligne (3) cancer (3) Dose-response relationship (3) Blockades (3) Cancer (3) Inhibitors (3) Dendritic cells (3) RNA (3) Psoriasis (3) Messenger RNA (3) Manufacturers' agents (3) Inhibition (3) Expression (3) Commission merchants (3) Cancer (3) Blockade (3) temps (durée) (2) thérapie (2) protéine (2) modèle (2) ADN (2) maladie (2) adulte (2)

Documents écrit par O. Demaria (8) | parle de O. Demaria (0)

Type I IFNs link skin-associated dysbiotic commensal bacteria to pathogenic inflammation and angiogenesis in rosacea.
A. Mylonas et al. (22 févr. 2023)
TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis.
C. Conrad et al. (2 janv. 2018)
Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth.
B. Bujisic et al. (27 avr. 2017)
Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris.
L. Feldmeyer et al. (1 avr. 2017)
Pharmacological eEF2K activation promotes cell death and inhibits cancer progression.
A. De Gassart et al.
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
O. Demaria et al. (2015)
Immune sensing of nucleic acids in inflammatory skin diseases.
O. Demaria et al. (2014)
TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNA.
I. Perrot et al. (2010)